Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t
about
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaPositron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patientsFourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignanciesPembrolizumab in classical Hodgkin's lymphomaHodgkin lymphoma, version 2.2015.Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab.Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.Advanced hodgkin lymphoma: a new era of therapy.Hodgkin disease-an ever-evolving therapy.The Management of Classical Hodgkin's Lymphoma: Past, Present, and FutureEmerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab VedotinRandomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 TrialThe European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the ComOmitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaSexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study GroupEvolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literatureHematological cancer in 2011: New therapeutic targets and treatment strategies.State of the art in the treatment of Hodgkin lymphoma.Modern radiotherapeutic strategies in the management of lymphoma.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma.No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.Hodgkin lymphoma: highlights from the 2012 European School of Hematology International Conference.CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.
P2860
Q24186668-E008D1F9-31F3-49AC-A037-A832A51D86BAQ24202622-D9D1AB89-EF1A-4489-BE85-2F5466D153D7Q26830130-A8CCA087-D8EC-4835-AC7F-D128033162AEQ28079273-61BC4E90-A844-4A8C-8E14-FF0578209399Q30769157-F352A2CD-DB6F-4E2C-97CE-20775C442A93Q33406827-970C4831-A879-44E6-B43D-27494650BA4AQ33442092-CEAF7ECB-B613-4436-A949-E16FEFA91915Q33704061-52D143D9-CD36-4278-9D40-5247EB01A138Q33935351-74A4D440-0E2F-4733-B248-8B7DF19B72E2Q34194160-8FF82B89-B658-44BF-B556-7CB4742E2434Q34463426-4AA53042-9787-4AA2-BEAC-D8E73FD67710Q35038852-EBBBC603-E40B-4862-89F9-8FFA747B1902Q35669134-06C1C63B-F539-4042-A655-40FD9E942495Q35671369-3F99A3A0-2375-477C-874B-34A0B8860055Q36452273-59667D2B-66F7-4E23-8465-E8497DB02659Q36508230-710AE63B-70DF-4995-B847-A77335277BE6Q36557416-CAE2BE1F-2194-4756-B771-826911067CF6Q36557883-E9E13A40-EF65-47B9-A1F2-6AD55BEEC667Q37178817-4CB88ED6-765C-4947-A470-2F8C46951665Q37974569-9182E40F-E132-4329-987F-5EEC4E201F06Q38017914-808EE031-2358-40FD-BEDC-288A93706911Q38373945-F606F849-B465-4AF4-966A-579629232AFDQ38688797-F7B54B40-ABBB-4CB5-AEE9-DC43940276A0Q38775871-EB762368-2476-4795-BB55-39622C093A3CQ38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2BQ40929122-8B1B2151-3F8A-44B1-83E5-F0BE948BF16DQ41378943-524039CC-FFEA-462C-8B64-BB0244780930Q42287385-B45A8186-025F-4206-9B5D-36CEAAB05BC7Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2BQ44193375-7446CE98-1C83-46C9-90E3-52DDE73DFDD1Q45283058-589AEAD0-403B-4D80-BFDC-4AC081E46D57Q45825739-9F5779CF-B927-4BAC-B123-12E6738E4960Q47437693-43E5149F-87C0-4B10-ACC5-97F4A975360EQ48921913-B2525A8C-5EBB-4257-BF97-C34B317917AFQ50044569-FC484C70-1BA2-4212-A71D-9495C6300CDAQ50054777-CC8B6C2C-3927-4AC9-8864-151AC0A9C183Q51127733-168B99F1-EBD5-4795-AE3A-8662D71FE5BEQ52722711-DD6371C1-AEE0-4F04-8C79-0B2BAD3BBED2
P2860
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@ast
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@en
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@nl
type
label
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@ast
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@en
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@nl
prefLabel
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@ast
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@en
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@nl
P2093
P356
P1476
Eight cycles of escalated-dose ...... : final analysis of the HD12 t
@en
P2093
Andreas Engert
Andreas Rank
Anthony D Ho
Bernd Dörken
Christoph Huber
Christoph Nerl
Hans Konrad Mueller-Hermelink
Hans-Theodor Eich
Heinz Haverkamp
Jana Markova
P304
P356
10.1200/JCO.2010.33.9549
P407
P577
2011-10-11T00:00:00Z